BioCentury | Feb 2, 2015
Politics, Policy & Law

Dr. Califf goes to Washington

...Institute Inc. Li Ka Shing Knowledge Institute Medscape LLC Medtronic plc Merck & Co. Inc. Nile Therapeutics Inc....
BioCentury | Jan 20, 2014
Company News

SMC Biotechnology management update

...Inc. , Redwood City, Calif. Business: Musculoskeletal Hired: Darlene Horton as CMO, formerly CEO of Nile Therapeutics Inc....
BioCentury | Nov 25, 2013
Company News

Capricor Therapeutics deal

...Capricor Inc. completed its reverse merger with Nile Therapeutics Inc. The surviving company, Capricor Therapeutics, will begin trading...
BioCentury | Nov 4, 2013
Strategy

Teva blinks

...as chairman at Arno Therapeutics Inc. (OTCQB:ARNI) and TheraCoat Ltd. and is a director at Nile Therapeutics Inc....
BioCentury | Jul 15, 2013
Company News

Capricor, Nile Therapeutics deal

...but has been unable to raise the necessary capital. Capricor Inc. , Los Angeles, Calif. Nile Therapeutics Inc....
BioCentury | Aug 20, 2012
Company News

Myrexis autoimmune, cancer news

...and Canada. More recently, Brewer served as chairman of Dendreon Corp. (NASDAQ:DNDN, Seattle, Wash.) and Nile Therapeutics Inc....
BioCentury | Aug 16, 2012
Company News

Veteran biotech exec Brewer passes away

...Genentech Europe and Canada. More recently, Brewer served as chairman of Dendreon Corp. (NASDAQ:DNDN) and Nile Therapeutics Inc....
BioCentury | Aug 13, 2012
Company News

Nile Therapeutics management update

Nile Therapeutics Inc. (OTCQB:NLTX), San Mateo, Calif. Business: Cardiovascular Promoted: Darlene Horton to president, CEO and a director from CMO; Interim President and CEO Joshua Kazam will resign while remaining a director WIR Staff...
BioCentury | Jun 25, 2012
Company News

Nile Therapeutics management update

Nile Therapeutics Inc. (OTCQB:NLTX), San Mateo, Calif. Business: Cardiovascular Hired: Darlene Horton as CMO, formerly CMO of Itero Biopharmaceuticals Inc. WIR Staff...
BioCentury | Apr 9, 2012
Financial News

Nile Therapeutics completes direct public offering

Nile Therapeutics Inc. (OTCQB:NLTX), San Mateo, Calif. Business: Cardiovascular Date completed: 3/30/12 Type: Direct public offering Raised: $1.3 million Shares: 3.4 million Price: $0.40 Shares after offering: 43.1 million Placement agent: Roth Capital Partners Note:...
Items per page:
1 - 10 of 55
BioCentury | Feb 2, 2015
Politics, Policy & Law

Dr. Califf goes to Washington

...Institute Inc. Li Ka Shing Knowledge Institute Medscape LLC Medtronic plc Merck & Co. Inc. Nile Therapeutics Inc....
BioCentury | Jan 20, 2014
Company News

SMC Biotechnology management update

...Inc. , Redwood City, Calif. Business: Musculoskeletal Hired: Darlene Horton as CMO, formerly CEO of Nile Therapeutics Inc....
BioCentury | Nov 25, 2013
Company News

Capricor Therapeutics deal

...Capricor Inc. completed its reverse merger with Nile Therapeutics Inc. The surviving company, Capricor Therapeutics, will begin trading...
BioCentury | Nov 4, 2013
Strategy

Teva blinks

...as chairman at Arno Therapeutics Inc. (OTCQB:ARNI) and TheraCoat Ltd. and is a director at Nile Therapeutics Inc....
BioCentury | Jul 15, 2013
Company News

Capricor, Nile Therapeutics deal

...but has been unable to raise the necessary capital. Capricor Inc. , Los Angeles, Calif. Nile Therapeutics Inc....
BioCentury | Aug 20, 2012
Company News

Myrexis autoimmune, cancer news

...and Canada. More recently, Brewer served as chairman of Dendreon Corp. (NASDAQ:DNDN, Seattle, Wash.) and Nile Therapeutics Inc....
BioCentury | Aug 16, 2012
Company News

Veteran biotech exec Brewer passes away

...Genentech Europe and Canada. More recently, Brewer served as chairman of Dendreon Corp. (NASDAQ:DNDN) and Nile Therapeutics Inc....
BioCentury | Aug 13, 2012
Company News

Nile Therapeutics management update

Nile Therapeutics Inc. (OTCQB:NLTX), San Mateo, Calif. Business: Cardiovascular Promoted: Darlene Horton to president, CEO and a director from CMO; Interim President and CEO Joshua Kazam will resign while remaining a director WIR Staff...
BioCentury | Jun 25, 2012
Company News

Nile Therapeutics management update

Nile Therapeutics Inc. (OTCQB:NLTX), San Mateo, Calif. Business: Cardiovascular Hired: Darlene Horton as CMO, formerly CMO of Itero Biopharmaceuticals Inc. WIR Staff...
BioCentury | Apr 9, 2012
Financial News

Nile Therapeutics completes direct public offering

Nile Therapeutics Inc. (OTCQB:NLTX), San Mateo, Calif. Business: Cardiovascular Date completed: 3/30/12 Type: Direct public offering Raised: $1.3 million Shares: 3.4 million Price: $0.40 Shares after offering: 43.1 million Placement agent: Roth Capital Partners Note:...
Items per page:
1 - 10 of 55